{"transactions":[{"id":4627493,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T20:05:44.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period."}],"balance_after":58965,"source":{"system":"sec-edgar","filing":"0001104659-26-111346","document":"tm2626098-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465926111346/tm2626098-5_4seq1.xml","form_type":"4"}},{"id":1040471,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T16:06:00.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025."}],"balance_after":30965,"source":{"system":"sec-edgar","filing":"0001104659-25-089997","document":"tm2526001-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465925089997/tm2526001-4_4seq1.xml","form_type":"4"}},{"id":1114925,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-11T16:05:18.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on June 10, 2026."}],"balance_after":12500,"derivative":{"exercise_price":0.33,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001641172-25-014692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000164117225014692/ownership.xml","form_type":"4"}},{"id":1173287,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:17.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250,"price":0.39,"value":97.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":355.2,"exercise_date":"2018-06-28","expiration_date":"2025-06-28","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001641172-25-003821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000164117225003821/ownership.xml","form_type":"4"}},{"id":1173286,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:17.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":281,"price":0.39,"value":109.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":480,"exercise_date":"2016-05-22","expiration_date":"2026-05-22","underlying":"Common Stock","underlying_shares":281},"source":{"system":"sec-edgar","filing":"0001641172-25-003821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000164117225003821/ownership.xml","form_type":"4"}},{"id":1173285,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:17.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250,"price":0.39,"value":97.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":388.64,"exercise_date":"2019-06-28","expiration_date":"2026-06-28","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001641172-25-003821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000164117225003821/ownership.xml","form_type":"4"}},{"id":1173284,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:17.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500,"price":0.39,"value":195.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":24.6,"exercise_date":"2020-07-15","expiration_date":"2027-07-15","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001641172-25-003821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000164117225003821/ownership.xml","form_type":"4"}},{"id":1486787,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T17:00:17.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on June 6, 2025."}],"balance_after":12500,"derivative":{"exercise_price":2.63,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-24-023152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000149315224023152/ownership.xml","form_type":"4"}},{"id":1586784,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-08T16:20:27.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period."}],"balance_after":219290,"source":{"system":"sec-edgar","filing":"0001104659-24-032411","document":"tm248350-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465924032411/tm248350-5_4seq1.xml","form_type":"4"}},{"id":1874850,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T16:15:50.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on May 25, 2024."}],"balance_after":12500,"derivative":{"exercise_price":1.82,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-23-019462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000149315223019462/ownership.xml","form_type":"4"}},{"id":2147310,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T16:31:44.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on September 30, 2023."}],"balance_after":13750,"derivative":{"exercise_price":2.16,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001493152-22-027441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000149315222027441/ownership.xml","form_type":"4"}},{"id":2151389,"issuer":{"id":121490,"kind":"organization","name":"CYREN Ltd.","symbol":"CYRN"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-09-26T16:11:26.000Z","date":"2022-09-22","kind":"grant","acquired":true,"shares":17500,"price":1.18,"value":20650.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer. The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date of September 22, 2022."}],"balance_after":25197,"source":{"system":"sec-edgar","filing":"0001628280-22-025470","document":"wf-form4_166422307113339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084577/000162828022025470/wf-form4_166422307113339.xml","form_type":"4"}},{"id":2261836,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T17:02:44.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":149290,"source":{"system":"sec-edgar","filing":"0001104659-22-063451","document":"tm2216123-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465922063451/tm2216123-6_4seq1.xml","form_type":"4"}},{"id":2611493,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-06T17:00:23.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on August 4, 2022."}],"balance_after":13750,"derivative":{"exercise_price":8.87,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001493152-21-018908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000149315221018908/ownership.xml","form_type":"4"}},{"id":2626389,"issuer":{"id":121490,"kind":"organization","name":"CYREN Ltd.","symbol":"CYRN"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-07-23T17:34:48.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on July 21, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a reduction of shares to correct an error in the number previously reported."}],"balance_after":153931,"source":{"system":"sec-edgar","filing":"0001213900-21-038430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084577/000121390021038430/ownership.xml","form_type":"4"}},{"id":2900770,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-01-21T16:08:02.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":20147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter."}],"balance_after":69290,"source":{"system":"sec-edgar","filing":"0001104659-21-006291","document":"tm213677-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465921006291/tm213677-5_4seq1.xml","form_type":"4"}},{"id":2916723,"issuer":{"id":121490,"kind":"organization","name":"CYREN Ltd.","symbol":"CYRN"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-06T16:22:00.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2022."}],"balance_after":128931,"source":{"system":"sec-edgar","filing":"0001213900-21-000677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084577/000121390021000677/ownership.xml","form_type":"4"}},{"id":3002899,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-20T16:09:40.000Z","date":"2020-10-16","kind":"purchase","acquired":true,"shares":1372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2020."}],"balance_after":49143,"source":{"system":"sec-edgar","filing":"0001104659-20-116436","document":"tm2033754d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465920116436/tm2033754d5_4.xml","form_type":"4"}},{"id":3077857,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T16:08:54.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":2378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2020."}],"balance_after":47771,"source":{"system":"sec-edgar","filing":"0001104659-20-085624","document":"tm2025176d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465920085624/tm2025176d4_4.xml","form_type":"4"}},{"id":3080521,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T16:33:53.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023."}],"balance_after":40000,"derivative":{"exercise_price":0.3075,"expiration_date":"2027-07-15","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-20-017810","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000121390020017810/ownership.xml","form_type":"4"}},{"id":3180714,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T16:08:14.000Z","date":"2020-04-03","kind":"purchase","acquired":true,"shares":2378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2020."}],"balance_after":45393,"source":{"system":"sec-edgar","filing":"0001104659-20-044160","document":"tm2015091d9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465920044160/tm2015091d9_4.xml","form_type":"4"}},{"id":3270743,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T16:15:18.000Z","date":"2020-02-12","kind":"purchase","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43015,"source":{"system":"sec-edgar","filing":"0001104659-20-021770","document":"tm207834-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465920021770/tm207834-4_4.xml","form_type":"4"}},{"id":3297745,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-30T16:07:54.000Z","date":"2020-01-28","kind":"purchase","acquired":true,"shares":2378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2019."}],"balance_after":13015,"source":{"system":"sec-edgar","filing":"0001104659-20-008685","document":"tm206156d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465920008685/tm206156d4_4.xml","form_type":"4"}},{"id":3315491,"issuer":{"id":121490,"kind":"organization","name":"CYREN Ltd.","symbol":"CYRN"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-01-08T17:06:21.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 06, 2021."}],"balance_after":108931,"source":{"system":"sec-edgar","filing":"0001213900-20-000551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084577/000121390020000551/ownership.xml","form_type":"4"}},{"id":3331324,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-26T16:07:17.000Z","date":"2019-12-23","kind":"purchase","acquired":true,"shares":2378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2019 in the aggregate amount of $10,250."}],"balance_after":10637,"source":{"system":"sec-edgar","filing":"0001104659-19-076121","document":"tm1927375-5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000110465919076121/tm1927375-5_4.xml","form_type":"4"}},{"id":3464169,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-10T16:05:46.000Z","date":"2019-07-09","kind":"purchase","acquired":true,"shares":34166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first and second quarters of 2019 in the aggregate amount of $20,500."}],"balance_after":165158,"source":{"system":"sec-edgar","filing":"0001144204-19-034301","document":"tv524964_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420419034301/tv524964_4.xml","form_type":"4"}},{"id":3471330,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-02T16:37:39.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on June 28, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through June 28, 2022."}],"balance_after":20000,"derivative":{"exercise_price":4.858,"expiration_date":"2026-06-28","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-19-011967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000121390019011967/ownership.xml","form_type":"4"}},{"id":3545586,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-30T17:01:07.000Z","date":"2019-04-29","kind":"purchase","acquired":true,"shares":25109,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130992,"source":{"system":"sec-edgar","filing":"0001144204-19-022462","document":"tv520234_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420419022462/tv520234_4.xml","form_type":"4"}},{"id":3683874,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-29T16:03:38.000Z","date":"2019-01-27","kind":"purchase","acquired":true,"shares":10250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2018 in the amount of $10,250."}],"balance_after":105883,"source":{"system":"sec-edgar","filing":"0001144204-19-003512","document":"tv511866_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420419003512/tv511866_4.xml","form_type":"4"}},{"id":3688354,"issuer":{"id":121490,"kind":"organization","name":"CYREN Ltd.","symbol":"CYRN"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-01-24T17:36:39.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 22, 2020."}],"balance_after":88931,"source":{"system":"sec-edgar","filing":"0001213900-19-001187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1084577/000121390019001187/ownership.xml","form_type":"4"}},{"id":3754691,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T16:00:52.000Z","date":"2018-11-19","kind":"purchase","acquired":true,"shares":5000,"price":0.7,"value":3500.0,"ownership":{"direct":true},"balance_after":95633,"source":{"system":"sec-edgar","filing":"0001144204-18-061225","document":"tv507651_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418061225/tv507651_form4.xml","form_type":"4"}},{"id":3796019,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T16:22:13.000Z","date":"2018-10-03","kind":"grant","acquired":true,"shares":10312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $10,250."}],"balance_after":90633,"source":{"system":"sec-edgar","filing":"0001144204-18-052749","document":"tv504216_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418052749/tv504216_form4.xml","form_type":"4"}},{"id":3870379,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-10T16:07:20.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":7039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2018 in the amount of $10,250."}],"balance_after":80321,"source":{"system":"sec-edgar","filing":"0001144204-18-037841","document":"tv498260_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418037841/tv498260_form4.xml","form_type":"4"}},{"id":3900087,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T16:08:23.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":24343,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":73282,"source":{"system":"sec-edgar","filing":"0001144204-18-033548","document":"tv496165_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418033548/tv496165_4.xml","form_type":"4"}},{"id":3957215,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T16:08:07.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":6653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2018 in the amount of $10,250."}],"balance_after":48929,"source":{"system":"sec-edgar","filing":"0001144204-18-022376","document":"tv491864_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418022376/tv491864_4.xml","form_type":"4"}},{"id":4104279,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-08T16:14:52.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":6531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $10,250."}],"balance_after":42276,"source":{"system":"sec-edgar","filing":"0001144204-18-001302","document":"tv482693_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420418001302/tv482693_4.xml","form_type":"4"}},{"id":4180685,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T16:07:13.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":5521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $10,250."}],"balance_after":35745,"source":{"system":"sec-edgar","filing":"0001144204-17-054096","document":"tv477608_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420417054096/tv477608_4.xml","form_type":"4"}},{"id":4259113,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-11T16:08:27.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":4433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $10,250."}],"balance_after":30224,"source":{"system":"sec-edgar","filing":"0001144204-17-036440","document":"v470580_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420417036440/v470580_4.xml","form_type":"4"}},{"id":4351604,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T16:18:30.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $10,250."}],"balance_after":25791,"source":{"system":"sec-edgar","filing":"0001144204-17-020713","document":"v464365_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420417020713/v464365_4.xml","form_type":"4"}},{"id":4473616,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-01T16:05:37.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":16007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal quarterly installments commencing on January 30, 2017."}],"balance_after":16007,"derivative":{"exercise_price":3.202,"expiration_date":"2023-01-30","underlying":"Common Stock","underlying_shares":16007},"source":{"system":"sec-edgar","filing":"0001144204-17-005353","document":"v457878_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420417005353/v457878_4.xml","form_type":"4"}},{"id":4491154,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":75373,"kind":"person","name":"Karah Hila","position":1,"cik":"0001668116","reported_name":"Karah Hila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-13T16:37:20.000Z","date":"2017-01-12","kind":"grant","acquired":true,"shares":6388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter and fourth quarter of 2016 in the amount of $20,500."}],"balance_after":22991,"source":{"system":"sec-edgar","filing":"0001144204-17-002208","document":"v456898_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668116/000114420417002208/v456898_4.xml","form_type":"4"}}]}